The estimated Net Worth of Kevin Unger is at least $155 Thousand dollars as of 13 September 2018. Mr. Unger owns over 1,000 units of OrthoPediatrics corp stock worth over $43,680 and over the last 6 years he sold KIDS stock worth over $33,220. In addition, he makes $77,786 as Independent Director at OrthoPediatrics corp.
Kevin has made over 1 trades of the OrthoPediatrics corp stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 1,000 units of KIDS stock worth $33,220 on 13 September 2018.
The largest trade he's ever made was selling 1,000 units of OrthoPediatrics corp stock on 13 September 2018 worth over $33,220. On average, Kevin trades about 167 units every 0 days since 2018. As of 13 September 2018 he still owns at least 1,400 units of OrthoPediatrics corp stock.
You can see the complete history of Mr. Unger stock trades at the bottom of the page.
Kevin L. Unger serves as Independent Director of the Company. Mr. Unger is currently the Chief Executive Officer of Columbia Nutritional, LLC, a nutritional supplement manufacturing company, a position he has held since 2015. He served as the Chief Executive Officer of Intrinsic Healthcare Inc. from 2011 to 2015. Prior to founding Intrinsic, he served as the Global President of Orthofix International N.V., a spinal implant and biologics business, from 2009 to 2011. Mr. Unger held various roles for Stryker Corporation from 1994 to 2009, ultimately becoming a Vice President and General Manager in the MedSurg division.
As the Independent Director of OrthoPediatrics corp, the total compensation of Kevin Unger at OrthoPediatrics corp is $77,786. There are 13 executives at OrthoPediatrics corp getting paid more, with Mark Throdahl having the highest compensation of $1,190,150.
Kevin Unger is 48, he's been the Independent Director of OrthoPediatrics corp since 2011. There are 16 older and 3 younger executives at OrthoPediatrics corp. The oldest executive at OrthoPediatrics corp is Stephen Burns, 76, who is the Independent Director.
Kevin's mailing address filed with the SEC is 2850 Frontier Dr, Warsaw, IN 46582, USA.
Over the last 17 years, insiders at OrthoPediatrics corp have traded over $17,595,944 worth of OrthoPediatrics corp stock and bought 44,994 units worth $1,275,983 . The most active insiders traders include David R Pelizzon, John V. Schaefer, and Mark C Throdahl. On average, OrthoPediatrics corp executives and independent directors trade stock every 24 days with the average trade being worth of $158,746. The most recent stock trade was executed by Daniel J Gerritzen on 21 August 2024, trading 10,000 units of KIDS stock currently worth $293,000.
orthopediatrics is the worldwide leader in pediatric orthopedics. we are the first company whose total focus is helping children with orthopaedic conditions and injuries by providing the surgeons who care for them with anatomically appropriate implants. every day, we focus purely on advancing the field of pediatric orthopedics through the innovative development of state-of-the-art technologies, commitment to quality products, and industry-leading support and clinical education with our experienced team of experts. our offering is continuing to expand as we strive to develop all of the necessary implants and instruments that a pediatric orthopedic surgeon needs to treat his/her patients, including: long bone deformity correction & trauma, spine, and sports medicine. as we continue to grow, we are looking for talented professionals to join our cause! visit our website to learn more about current openings, or submit a resume to careers@orthopediatrics.com!
OrthoPediatrics corp executives and other stock owners filed with the SEC include: